Galt Global Review

QFS 360

Are Pharmaceutical Drug Prices Justified by Research & Development
September 2002

In only 5 out of 12 countries surveyed did a majority agree that current drug prices are justified by the cost of research and development. On the positive side, in all 12 countries majorities agree that the benefits of pharmaceutical drugs in treating illness far outweigh the risk of side effects.

Consumers Split on Whether R&D Justifies Drug Prices.

When asked, " Do you agree or disagree: Pharmaceutical drug prices are justified because companies need money to research and develop new drugs?"

 
agree

disagree

Urban India
61%
25%
United Kingdom
58%
38%
France
57%
42%
Canada
57%
43%
Urban South Africa
50%
31%
United States
47%
53%
Urban China
46%
47%
Japan
41%
59%
Germany
39%
58%
South Korea
36%
59%
Urban Brazil
35%
62%
Urban Russia
32%
50%

Two-thirds (65%) Believe the Benefits of Pharmaceutical Drugs Far Outweigh the Risks

On another question in the survey, two-thirds (65%) of the 12 countries surveyed feel that the benefits of modern pharmaceutical drugs in treating illness far outweigh the risk of side effects.

  • In the U.S. the figure is 64%.
  • Residents of urban India (76%), France (71%) and urban Brazil (70%) are most likely to agree.
  • From a global perspective, men (67%) and women (63%) both seem convinced of the benefits.

Global Research Methodology

These international survey research data were collected via Ipsos-Reid's Global Express, a quarterly international omnibus survey. Fieldwork was conducted between February 20 and March 20, 2002.

About Ipsos-Reid

Ipsos-Reid has been tracking public opinion around the world for over 20 years and has become a leading provider of global public opinion and market research to public, private and not-for-profit organizations in over 50 countries. It is a member of the Paris-based Ipsos Group, ranked among the top ten research groups in the world.

For more information about this poll please contact:

Edward Morawski
Ipsos-Reid
(212)265-3200

For other inquiries contact:
North America:
Gus Schattenberg, Vice President
Ipsos Reid, Vancouver
604-893-1606
Europe:
Douglas Rosane, Director
Ipsos Management, Paris
(33) 1 53 68 19 67

 

 

 

Return to Top